University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Roulstone, VUNSPECIFIEDUNSPECIFIED
Khan, KUNSPECIFIEDUNSPECIFIED
Pandha, HSh.pandha@surrey.ac.ukUNSPECIFIED
Rudman, SUNSPECIFIEDUNSPECIFIED
Coffey, MUNSPECIFIEDUNSPECIFIED
Gill, GMUNSPECIFIEDUNSPECIFIED
Melcher, AAUNSPECIFIEDUNSPECIFIED
Vile, RUNSPECIFIEDUNSPECIFIED
Harrington, KJUNSPECIFIEDUNSPECIFIED
de Bono, JUNSPECIFIEDUNSPECIFIED
Spicer, JUNSPECIFIEDUNSPECIFIED
Date : 15 March 2015
Identification Number : https://doi.org/10.1158/1078-0432.CCR-14-1770
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, ADVANCED CANCER, TYPE-3, CHEMOTHERAPY, CYCLOSPORINE, COMBINATION, EFFICACY, THERAPY, INNATE, I/II
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:27
Last Modified : 17 May 2017 14:49
URI: http://epubs.surrey.ac.uk/id/eprint/827834

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800